RASi targeting of the tumor stroma resulted in collagen I synthesis inhibition by CAFs in a dose-dependent manner in different desmoplastic models including human breast, pancreatic, and skin tumors in mice [95]. The gene discussed is MMP19; the disease is neoplasm.